InMode Ltd.(INMD)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,407 of 2,960 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
INMD Stock Analysis & AI Quality Score
Data updated 2026-09-12AI stock analysis and institutional research for InMode Ltd. (INMD), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores INMD at 53.1/100 on a 32-signal composite quality model, placing it at rank #1,407 of 2,960 stocks — the top half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), InMode Ltd. reports quarterly revenue of $370.5M, net income of $93.8M, an operating margin of 23.1%. Top institutional holders of INMD by reported 13-F value include Doma Perpetual Capital Management, ACADIAN ASSET MANAGEMENT, BlackRock, based on the most recent SEC filings. INMD trades on the Nasdaq exchange and files with the SEC under CIK 1742692. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for InMode Ltd. directly from SEC EDGAR. InMode Ltd.'s 13F Pro composite quality score has ranged between 52 and 54 since 2026, currently 53.1 — a stable long-term trajectory across 48 quarterly and live scoring snapshots.
Revenue
FY 2025
$370.5M
Net Income
FY 2025
$93.8M
Free Cash Flow
FY 2025
$84.3M
Operating Margin
FY 2025
23.1%
ROIC
FY 2025
12.5%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-6.2% YoYNet Income
Operating Income
-24.1% YoYEPS (Diluted)
-36.4% YoYTotal Assets
-2.4% YoYOp. Cash Flow
-35.7% YoYFree Cash Flow
-36.1% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $370.5M -6.2% | $394.8M -19.8% | $492.0M +8.3% | $454.3M +27.0% | $357.6M +73.5% | $206.1M |
| Net Income | — | — | $197.9M +22.5% | $161.5M -2.1% | $165.0M +119.9% | $75.0M |
| Operating Income | $85.4M -24.1% | $112.5M -42.5% | $195.7M -1.1% | $197.9M +18.1% | $167.5M +129.9% | $72.8M |
| EPS (Diluted) | $1.43 -36.4% | $2.25 -2.2% | $2.30 +21.7% | $1.89 -1.6% | $1.92 +115.7% | $0.89 |
| Total Assets | $766.4M -2.4% | $785.7M -9.0% | $863.3M +34.0% | $644.4M +34.7% | $478.5M +61.8% | $295.8M |
| Operating Cash Flow | $85.3M -35.7% | $132.7M -25.0% | $176.8M -2.6% | $181.6M +3.8% | $174.9M +120.7% | $79.2M |
| Free Cash Flow | $84.3M -36.1% | $132.0M -25.1% | $176.1M -2.2% | $180.0M +3.5% | $173.9M +120.9% | $78.8M |
Get alerted when INMD's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for InMode Ltd. including:
Top Institutional Holders of INMD
Doma Perpetual Capital Management LLC
$39.9M2,730,931 shACADIAN ASSET MANAGEMENT LLC
$37.8M2,583,988 shBlackRock, Inc.
$36.5M2,495,402 shRENAISSANCE TECHNOLOGIES LLC
$35.0M2,391,318 shMENORA MIVTACHIM HOLDINGS LTD.
$29.8M2,040,000 shSTEEL PARTNERS HOLDINGS L.P.
$26.7M1,828,815 shMILLENNIUM MANAGEMENT LLC
$25.6M1,751,972 shMORGAN STANLEY
$16.3M1,115,207 shSYSTEMATIC FINANCIAL MANAGEMENT LP
$14.9M1,015,754 shJupiter Topco LLC
$14.1M966,020 sh
| Fund | Value | Shares |
|---|---|---|
| Doma Perpetual Capital Management LLC | $39.9M | 2,730,931 |
| ACADIAN ASSET MANAGEMENT LLC | $37.8M | 2,583,988 |
| BlackRock, Inc. | $36.5M | 2,495,402 |
| RENAISSANCE TECHNOLOGIES LLC | $35.0M | 2,391,318 |
| MENORA MIVTACHIM HOLDINGS LTD. | $29.8M | 2,040,000 |
| STEEL PARTNERS HOLDINGS L.P. | $26.7M | 1,828,815 |
| MILLENNIUM MANAGEMENT LLC | $25.6M | 1,751,972 |
| MORGAN STANLEY | $16.3M | 1,115,207 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $14.9M | 1,015,754 |
| Jupiter Topco LLC | $14.1M | 966,020 |
Companies Similar to INMD
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
PUMA BIOTECHNOLOGY, INC.
Embecta Corp.
COMPUGEN LTD
Amphastar Pharmaceuticals, Inc.
Lantheus Holdings, Inc.
Pacira BioSciences, Inc.
UTAH MEDICAL PRODUCTS INC
BIO-TECHNE Corp
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put INMD on your watchlist
Track score changes the day InMode Ltd. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is INMD a good stock to buy?
13F Pro's AI-powered analysis of InMode Ltd. (INMD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for INMD are available on the INMD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. INMD is classified as a small company.
Which hedge funds own INMD?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling INMD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of InMode Ltd.'s investment landscape.